Skip navigation

Roche Holding Ltd.

Pharmaceuticals
Switzerland
2016 Revenue (US$ Millions)$51,710
Revenue Growth (%)4.43%
Net Income (US$ Millions)$9,408
Earnings Per Share (US$)$10.93
EPS Growth Rate (%)8.27%
Profit Margin18.19%
Total Equity (US$ Millions)$23,490
Return on Equity (%)45.65%
Long Term Debt (US$ Millions)$16,693
Debt To Equity Ratio (%)0.71%
Total Assets (US$ Millions)$75,468
Current Assets (US$ Millions)$28,166
Current Liabilities (US$ Millions)$22,203
Cost of Goods Sold (US$ Millions)$15,895
Inventory Turnover2.08